Cargando…

Sonodynamic Effects of a Novel Ether-Group Modified Porphyrin Derivative Combined With Pulsed Low-Intensity Ultrasound on PC-9 Cells

Sonodynamic therapy (SDT) is a developing modality for cancer treatment based on the synergistic effect of ultrasound and chemical compounds which are known as sonosensitizers. The development of more efficient sonosensitizers has become an urgent issue in this field. In this study, a novel porphyri...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Yinghua, Zhou, Qi, Geng, Jianxiong, Meng, Qingwei, Wei, Zixin, Ding, Meijuan, Zhou, Jing, Zeng, Yuan, Cao, Wenwu, Liu, Fang, Yu, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8685451/
https://www.ncbi.nlm.nih.gov/pubmed/34938196
http://dx.doi.org/10.3389/fphar.2021.792360
_version_ 1784617839250898944
author Jin, Yinghua
Zhou, Qi
Geng, Jianxiong
Meng, Qingwei
Wei, Zixin
Ding, Meijuan
Zhou, Jing
Zeng, Yuan
Cao, Wenwu
Liu, Fang
Yu, Yan
author_facet Jin, Yinghua
Zhou, Qi
Geng, Jianxiong
Meng, Qingwei
Wei, Zixin
Ding, Meijuan
Zhou, Jing
Zeng, Yuan
Cao, Wenwu
Liu, Fang
Yu, Yan
author_sort Jin, Yinghua
collection PubMed
description Sonodynamic therapy (SDT) is a developing modality for cancer treatment based on the synergistic effect of ultrasound and chemical compounds which are known as sonosensitizers. The development of more efficient sonosensitizers has become an urgent issue in this field. In this study, a novel porphyrin derivative (BBTPP) mediated SDT was evaluated on PC-9 cells. Pulsed low-intensity ultrasound (PLIU) was used for its little thermal and mechanical damage. The accumulation of drugs in cells was evaluated through porphyrin fluorescence, and the cytotoxicity of BBTPP was evaluated using a cell counting kit-8 assay. The sonodynamic effect was investigated by Hoechst 33342/PI and Annexin V-FITC/PI double staining, which showed an apoptotic rate of 18.87% in the BBTPP-SDT group, as compared with 1.71%, 1.4%, 1.57%, 3.61%, 11.18% in the control, BBTPP, hematoporphyrin monomethyl ether (HMME), ultrasound, and HMME-SDT groups, respectively. The sono-toxic effect of BBTPP was significantly superior to HMME. Our results showed that BBTPP-SDT resulted in much higher intracellular reactive oxygen species (ROS) and lipid peroxidation levels which were evaluated by 2′,7′-dichlorodihydrofluorescein diacetate (H(2)DCFDA) and Liperfluo assay, respectively. The expressions of Bax, Bcl-2, caspase-9, caspase-8, and cleaved caspase-3 proteins were evaluated to investigate the apoptotic mechanism of BBTPP-SDT. The results of this study showed that the combination of BBTPP and PLIU induced the generation of ROS, resulting in lipid peroxidation, and activated both the extrinsic and intrinsic apoptotic pathways of PC-9 cells. Our results also suggested that the ether group introduced in the side chain of porphyrin could enhance the sono-toxicity of porphyrin-based sensitizers under the sonication of PLIU. These results supported the possibility of BBTPP as a promising sonosensitizer, and an appropriate side chain could enhance the sono-sensitivity of porphyrins.
format Online
Article
Text
id pubmed-8685451
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-86854512021-12-21 Sonodynamic Effects of a Novel Ether-Group Modified Porphyrin Derivative Combined With Pulsed Low-Intensity Ultrasound on PC-9 Cells Jin, Yinghua Zhou, Qi Geng, Jianxiong Meng, Qingwei Wei, Zixin Ding, Meijuan Zhou, Jing Zeng, Yuan Cao, Wenwu Liu, Fang Yu, Yan Front Pharmacol Pharmacology Sonodynamic therapy (SDT) is a developing modality for cancer treatment based on the synergistic effect of ultrasound and chemical compounds which are known as sonosensitizers. The development of more efficient sonosensitizers has become an urgent issue in this field. In this study, a novel porphyrin derivative (BBTPP) mediated SDT was evaluated on PC-9 cells. Pulsed low-intensity ultrasound (PLIU) was used for its little thermal and mechanical damage. The accumulation of drugs in cells was evaluated through porphyrin fluorescence, and the cytotoxicity of BBTPP was evaluated using a cell counting kit-8 assay. The sonodynamic effect was investigated by Hoechst 33342/PI and Annexin V-FITC/PI double staining, which showed an apoptotic rate of 18.87% in the BBTPP-SDT group, as compared with 1.71%, 1.4%, 1.57%, 3.61%, 11.18% in the control, BBTPP, hematoporphyrin monomethyl ether (HMME), ultrasound, and HMME-SDT groups, respectively. The sono-toxic effect of BBTPP was significantly superior to HMME. Our results showed that BBTPP-SDT resulted in much higher intracellular reactive oxygen species (ROS) and lipid peroxidation levels which were evaluated by 2′,7′-dichlorodihydrofluorescein diacetate (H(2)DCFDA) and Liperfluo assay, respectively. The expressions of Bax, Bcl-2, caspase-9, caspase-8, and cleaved caspase-3 proteins were evaluated to investigate the apoptotic mechanism of BBTPP-SDT. The results of this study showed that the combination of BBTPP and PLIU induced the generation of ROS, resulting in lipid peroxidation, and activated both the extrinsic and intrinsic apoptotic pathways of PC-9 cells. Our results also suggested that the ether group introduced in the side chain of porphyrin could enhance the sono-toxicity of porphyrin-based sensitizers under the sonication of PLIU. These results supported the possibility of BBTPP as a promising sonosensitizer, and an appropriate side chain could enhance the sono-sensitivity of porphyrins. Frontiers Media S.A. 2021-12-06 /pmc/articles/PMC8685451/ /pubmed/34938196 http://dx.doi.org/10.3389/fphar.2021.792360 Text en Copyright © 2021 Jin, Zhou, Geng, Meng, Wei, Ding, Zhou, Zeng, Cao, Liu and Yu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Jin, Yinghua
Zhou, Qi
Geng, Jianxiong
Meng, Qingwei
Wei, Zixin
Ding, Meijuan
Zhou, Jing
Zeng, Yuan
Cao, Wenwu
Liu, Fang
Yu, Yan
Sonodynamic Effects of a Novel Ether-Group Modified Porphyrin Derivative Combined With Pulsed Low-Intensity Ultrasound on PC-9 Cells
title Sonodynamic Effects of a Novel Ether-Group Modified Porphyrin Derivative Combined With Pulsed Low-Intensity Ultrasound on PC-9 Cells
title_full Sonodynamic Effects of a Novel Ether-Group Modified Porphyrin Derivative Combined With Pulsed Low-Intensity Ultrasound on PC-9 Cells
title_fullStr Sonodynamic Effects of a Novel Ether-Group Modified Porphyrin Derivative Combined With Pulsed Low-Intensity Ultrasound on PC-9 Cells
title_full_unstemmed Sonodynamic Effects of a Novel Ether-Group Modified Porphyrin Derivative Combined With Pulsed Low-Intensity Ultrasound on PC-9 Cells
title_short Sonodynamic Effects of a Novel Ether-Group Modified Porphyrin Derivative Combined With Pulsed Low-Intensity Ultrasound on PC-9 Cells
title_sort sonodynamic effects of a novel ether-group modified porphyrin derivative combined with pulsed low-intensity ultrasound on pc-9 cells
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8685451/
https://www.ncbi.nlm.nih.gov/pubmed/34938196
http://dx.doi.org/10.3389/fphar.2021.792360
work_keys_str_mv AT jinyinghua sonodynamiceffectsofanovelethergroupmodifiedporphyrinderivativecombinedwithpulsedlowintensityultrasoundonpc9cells
AT zhouqi sonodynamiceffectsofanovelethergroupmodifiedporphyrinderivativecombinedwithpulsedlowintensityultrasoundonpc9cells
AT gengjianxiong sonodynamiceffectsofanovelethergroupmodifiedporphyrinderivativecombinedwithpulsedlowintensityultrasoundonpc9cells
AT mengqingwei sonodynamiceffectsofanovelethergroupmodifiedporphyrinderivativecombinedwithpulsedlowintensityultrasoundonpc9cells
AT weizixin sonodynamiceffectsofanovelethergroupmodifiedporphyrinderivativecombinedwithpulsedlowintensityultrasoundonpc9cells
AT dingmeijuan sonodynamiceffectsofanovelethergroupmodifiedporphyrinderivativecombinedwithpulsedlowintensityultrasoundonpc9cells
AT zhoujing sonodynamiceffectsofanovelethergroupmodifiedporphyrinderivativecombinedwithpulsedlowintensityultrasoundonpc9cells
AT zengyuan sonodynamiceffectsofanovelethergroupmodifiedporphyrinderivativecombinedwithpulsedlowintensityultrasoundonpc9cells
AT caowenwu sonodynamiceffectsofanovelethergroupmodifiedporphyrinderivativecombinedwithpulsedlowintensityultrasoundonpc9cells
AT liufang sonodynamiceffectsofanovelethergroupmodifiedporphyrinderivativecombinedwithpulsedlowintensityultrasoundonpc9cells
AT yuyan sonodynamiceffectsofanovelethergroupmodifiedporphyrinderivativecombinedwithpulsedlowintensityultrasoundonpc9cells